• bit.bio has undertaken a COVID-19 risk assessment and we are COVID secure
  • info@bit.bio
  • +44 (0) 1223 787 297
Bit Bio
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact

    News

    Talk | The cell programming revolution | CEO evening lecture at the Royal Institution

    Talk | The cell programming revolution | CEO evening lecture at the Royal Institution

    Jun 27, 2022

    Published by Royal Institution

    read more
    Article | bit.bio expands senior team with four female hires

    Article | bit.bio expands senior team with four female hires

    Jun 24, 2022

    Published by Cambridge Independent

    read more
    Press release | bit.bio named Emerging Star at European Mediscience Awards 2022

    Press release | bit.bio named Emerging Star at European Mediscience Awards 2022

    Jun 17, 2022

    Published by bit.bio

    read more
    Press release | bit.bio presents data at ISSCR demonstrating platform capability to create any human cell

    Press release | bit.bio presents data at ISSCR demonstrating platform capability to create any human cell

    Jun 16, 2022

    Published by bit.bio

    read more
    Article | Scalable, reproducible platform for reprogrammed human cells

    Article | Scalable, reproducible platform for reprogrammed human cells

    May 27, 2022

    Published by Nature Research Custom Media

    read more
    Article | bit.bio featured in The Sunday Telegraph

    Article | bit.bio featured in The Sunday Telegraph

    May 23, 2022

    Published by The Sunday Telegraph

    read more
    News | bit.bio wins two awards at Cambridge Independent Science and Tech Awards

    News | bit.bio wins two awards at Cambridge Independent Science and Tech Awards

    May 12, 2022

    Published by bit.bio

    read more
    Press release | bit.bio launches Huntington’s disease human cell model

    Press release | bit.bio launches Huntington’s disease human cell model

    May 9, 2022

    Published by bit.bio

    read more
    News | Rahul Singhvi, CEO National Resilience Inc. visits bit.bio labs

    News | Rahul Singhvi, CEO National Resilience Inc. visits bit.bio labs

    May 5, 2022

    Published by bit.bio

    read more
    Page 1 of 9 1 2 3 4 5 »

    Navigation

    • technology
    • about
    • careers
    • partner with us
    • resources
    • news
    • events
    • contact

    Products

    • ioGlutamatergic Neurons
    • ioSkeletal Myocytes
    • ioGABAergic Neurons
    • ioGlutamatergic Neurons HTT

    Subscribe to our newsletter

    ×

    Subscribe to our newsletter

    bit.bio © 2022 | All rights reserved | privacy policy | terms & conditions

    bit.bio © 2021 | All rights reserved
    privacy policy | terms & conditions